Adult Patients With Relapsed Or Primary Refractory Dlbcl clinical trials

Explore recruiting adult patients with relapsed or primary refractory dlbcl clinical trials.

Recruiting adult patients with relapsed or primary refractory dlbcl studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adult Patients With Relapsed Or Primary Refractory Dlbcl trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (Pola-R-ICE) with rituximab, ifosfamide, carboplatin and etoposide (R-ICE) alone as salvage therapy in patients with primary refractory or relapsed diffuse large B-cell lymphoma (DLBCL)

Spain, Austria, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Adult Patients With Relapsed Or Primary Refractory Dlbcl trials by city

Adult Patients With Relapsed Or Primary Refractory Dlbcl in Toronto Adult Patients With Relapsed Or Primary Refractory Dlbcl in Vancouver Adult Patients With Relapsed Or Primary Refractory Dlbcl in Montreal Adult Patients With Relapsed Or Primary Refractory Dlbcl in Calgary Adult Patients With Relapsed Or Primary Refractory Dlbcl in Edmonton Adult Patients With Relapsed Or Primary Refractory Dlbcl in Ottawa Adult Patients With Relapsed Or Primary Refractory Dlbcl in Winnipeg Adult Patients With Relapsed Or Primary Refractory Dlbcl in Quebec City Adult Patients With Relapsed Or Primary Refractory Dlbcl in Hamilton Adult Patients With Relapsed Or Primary Refractory Dlbcl in Kitchener Adult Patients With Relapsed Or Primary Refractory Dlbcl in London Adult Patients With Relapsed Or Primary Refractory Dlbcl in Halifax Adult Patients With Relapsed Or Primary Refractory Dlbcl in New York Adult Patients With Relapsed Or Primary Refractory Dlbcl in Los Angeles Adult Patients With Relapsed Or Primary Refractory Dlbcl in Chicago Adult Patients With Relapsed Or Primary Refractory Dlbcl in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease